FIELD: chemistry.
SUBSTANCE: invention concerns process of obtaining hydroxyl starch derivative which includes interaction of the reducing end of hydroxyalkyl starch represented by the formula (I), left unoxidised before this reaction, with a compound of formula (II) R'-NH-R", where R1 R2 and R3 independently denote hydrogen or linear or branched hydroxyalkyl group while R' or R" or R' and R" include at least one functional group X capable of interaction with at least one more compound before or after the reaction of (I) and (II). The invention also concerns hydroxyl starch derivative obtained in this process, and production process for hydroxyl starch derivative and polypeptide, a pharmaceutical composition incorporating the said hydroxyl starch derivatives.
EFFECT: improvement of compound production.
77 cl, 21 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING DERIVATIVES OF HYDROXYALKYL STARCH | 2003 |
|
RU2329274C2 |
POLYPEPTIDES TREATED WITH HAS, PARTICULARLY ERYTHROPOIETIN TREATED WITH HAS | 2003 |
|
RU2328505C2 |
HYDROXYALKYL STARCH AND G-CSF CONJUGATES | 2004 |
|
RU2370281C2 |
CONJUGATES OF HYDROXYALKYL STARCH AND ALLERGEN | 2003 |
|
RU2325925C2 |
TRANSPORT MEDIATING COLLOIDAL THERAPEUTIC COMPOUNDS | 2009 |
|
RU2519225C2 |
BONDING PRODUCTS OF AMINATED POLYSACCHARIDES | 2010 |
|
RU2549492C2 |
ERYTHROPOETIN APPLICATION | 2003 |
|
RU2305554C2 |
A CONJUGATE OF HYDROXYALKYL STARCH AND LOW-MOLECULAR SUBSTANCE AND METHOD OF OBTAINING IT | 2003 |
|
RU2327702C2 |
TREATMENT OF NEURODEGENERATIVE DISORDERS | 2006 |
|
RU2467761C2 |
CONJUGATES OF BLOOD COAGULATION PROTEINS | 2010 |
|
RU2595442C2 |
Authors
Dates
2008-06-20—Published
2003-08-08—Filed